Dr Lal PathLabs Q2 Results: Dr Lal PathLabs Limited, a prominent player in the Indian diagnostic and healthcare service sector, has reported a notable financial performance for the second quarter of ...
Dr. Om Manchanda, Managing Director at Dr. Lal PathLabs, is a summit seeker who has explored trails in Uttarakhand, Slovenia, Scotland, Italy, and Tanzania. Leading a healthcare giant in the country, ...
India's Dr Lal Path Labs beats quarterly profit view on medical testing boom Dr Lal Path Labs , India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday ...
Healthcare services provider Dr Lal PathLabs might be showing up to 50 per cent fall in some trading apps today.
Mumbai-based Jashvik Capital has marked the first close of its maiden $350 Mn fund. The private equity (PE) firm announced the fund in July 2022 with plans to close the same by July 2023. With this ...
The shares of Dr Lal PathLabs jumped more than 3 percent on October 27. This comes after the company announced that its board is set to meet on October 31 to consider a bonus issue of shares. The ...
Dr Lal PathLabs is set to see a sharp decline in its quoted share price on Friday, December 19, as the stock turned ex-date ...
BENGALURU, Aug 7 (Reuters) - Dr. Lal PathLabs (DLPA.NS), opens new tab reported first-quarter profit above expectations on Wednesday on strong demand for its medical tests in smaller cities and towns ...
About Dr. Lal PathLabs Ltd. Dr. Lal PathLabs Ltd. engages in the business of running laboratories for carrying out pathological investigations. It also involves in providing diagnostic and healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results